Sunday Letter · Body Desk

Reading your bloodwork at 50 — a layperson's guide

Most women walk out of their physical with a normal/abnormal sheet and zero context. Here are the eight markers that actually matter for the second-act decade, what the numbers mean, and the conversation worth having with your prescriber.

By Alexander Mills · Editor, After Forty Feel Reading time · 9 minutes

The first thing to know about adult bloodwork is that "normal" on a lab report is a statistical range, not a health verdict. A marker can sit inside reference and still be moving in a direction worth tracking. The doctor's eye is trained to flag values outside range. Your job — and the reason this letter exists — is to track trend: where did this number live five years ago, where does it live now, and what's the slope?

Two ground rules before the markers themselves.

One. Get a fasting CBC + comprehensive metabolic panel + lipid panel + HbA1c every year starting at 40. Insurance covers it. The lab is generally good. If your primary doesn't order them, your gyn often will. Or LabCorp's direct-to-consumer panel for ~$60 if you'd rather skip the appointment.

Two. Ask for the actual numbers, not just "normal." Most patient portals (MyChart, Epic, Cerner) show the values if you click into the result. Screenshot every one. Track them year over year in any spreadsheet. You'll see the slope long before any flag appears.

Now the markers, ranked by how much they actually tell you about your decade ahead.

The eight markers worth tracking

1. HbA1c (glycated hemoglobin)

Reference: <5.7%. Pre-diabetic: 5.7-6.4%. Diabetic: ≥6.5%

The single most useful marker on your panel. It reflects average blood sugar over the prior 3 months, not a snapshot. Women 40-60 with declining estrogen develop insulin resistance more often than people assume — visceral fat sensitivity to cortisol is part of it, sleep architecture shifts are another. If your HbA1c was 5.0 at 40 and is 5.5 at 50, that's a slope worth paying attention to, even though both numbers are "normal."

Action worth having: ask whether continuous glucose monitor (CGM) data would be useful at your trajectory. Two weeks on a Dexcom Stelo (~$90, no Rx needed in 2026) tells you which meals are actually spiking you. Not magazine speculation — your own postprandial curve.

2. Fasting insulin (NOT just fasting glucose)

Reference: 2.6-24.9 µIU/mL. Optimal: under 7 if you're looking to age well.

Most panels don't include this by default. Ask for it. Fasting glucose can look fine while insulin is climbing — that's the silent decade where insulin resistance builds before glucose breaks through. Combined with fasting glucose you can calculate HOMA-IR ((glucose × insulin) / 405). HOMA-IR under 1.0 is excellent; over 2.0 is meaningful insulin resistance even with normal glucose.

3. Lipid panel — specifically ApoB, not just LDL

ApoB reference: <90 mg/dL is conventional; under 60-70 is optimal for cardiovascular risk reduction in women 50+

The cardiology field shifted on this in the last decade. ApoB measures the actual count of atherogenic particles. LDL-cholesterol measures the cholesterol inside those particles, which can be misleading — you can have "normal" LDL with high particle count (small, dense LDL) and elevated cardiovascular risk. ApoB cuts through it.

The conversation worth having: if your ApoB is over 90, ask about a coronary artery calcium (CAC) score. It's a $100-150 CT scan you don't need a prescription for in most states, and it gives you a real number for cardiovascular risk over the next decade — more useful than a lipid panel alone.

4. TSH + free T3 + free T4

TSH: 0.4-4.0 mIU/L. Free T4: 0.8-1.8 ng/dL. Free T3: 2.3-4.2 pg/mL.

Thyroid issues are 5-8x more common in women than men and the incidence rises sharply in the 40s and 50s. If you ordered only TSH, that's the most common screening, but a "normal" TSH can mask suboptimal T3/T4 conversion. Symptoms — fatigue, cold intolerance, weight that won't move, dry skin — overlap with menopause so heavily that thyroid issues get missed.

If you're symptomatic and your TSH is in the upper-normal range (3.0-4.0), the full panel is worth running. Some endocrinologists will treat subclinical hypothyroidism if symptoms warrant it.

5. Vitamin D (25-OH)

Reference: 30-100 ng/mL. Optimal: 40-60 ng/mL.

Probably the marker most likely to be low and most likely to actually matter. In the second-act decade, vitamin D is linked to bone density, mood, immune function, and (most recently in 2024 meta-analyses) muscle protein synthesis. Below 30 ng/mL is deficient territory; below 20 is meaningfully so.

If you're low, dosing matters: 5,000 IU/day for 8-12 weeks then 2,000 IU/day maintenance is the typical protocol, but get retested at 12 weeks rather than guessing.

6. Ferritin (iron storage)

Reference: 11-307 ng/mL. Functional optimum for women 40-60: 50-150 ng/mL.

Ferritin tells you about iron stores, not the iron circulating in your blood right now. Many women in perimenopause carry "normal" hemoglobin but low ferritin — the iron stores have been quietly depleting through years of heavy cycles. Symptoms: fatigue that doesn't respond to sleep, restless legs at night, hair shedding.

If ferritin is under 30 and you're symptomatic, oral iron is the conventional first step but absorption is bad — every other day dosing actually beats daily in most studies. If under 15, ask about IV iron.

7. CBC differential — specifically RDW

Reference: 11.5-14.5%

An obscure marker most patients ignore. Red cell distribution width measures variability in red blood cell size. Elevated RDW (over 14.5%) is a predictor of mortality in women 50+, independent of anemia. It often reflects micronutrient issues (B12, folate, iron) or chronic inflammation. Worth flagging to your doctor if it's been creeping up year over year, even if everything else looks fine.

8. Hormones — FSH, estradiol, progesterone (if perimenopausal or considering HRT)

FSH: rises through perimenopause. Estradiol: highly variable. Progesterone: low in luteal phase post-40.

Single-point hormone draws are tricky because perimenopausal hormones bounce. FSH rising consistently above 25-30 IU/L on multiple draws suggests menopausal transition. Estradiol below 30 pg/mL alongside high FSH supports the picture. These numbers matter mostly for context if you're considering HRT — your prescriber will run them, and the actual decision about HRT depends more on symptom load than the lab number alone.

The 2023 HRT reanalyses (covered in our HRT post-WHI letter) updated the math on benefit-risk for many women in early menopause. The labs alone don't make the decision — the conversation with a prescriber familiar with current data does.

A practical thing: print out the table above before your next annual physical and bring it. Doctors are pressed for time and most are happy when patients show up prepared. "I'd like to add ApoB, fasting insulin, and a full thyroid panel to my labs this year" is a single sentence that gets you 80% of this letter's value.

What to do with the data

The number on the page is not the point. The slope is the point.

Your HbA1c at 50 doesn't tell you nearly as much as the line connecting your HbA1c at 40, 45, and 50. Same for ApoB. Same for vitamin D. Same for ferritin. The slope is what tells you whether your next decade is heading in a direction you can intervene on.

Set up a spreadsheet. Columns: marker, reference range, your value, your date, target. Add a row each year. By 55 you'll have a longitudinal view of your physiology that no doctor's office is keeping for you.

That's the actual edge of paying attention.

Like this letter?

Subscribe to the Sunday letter. One thoughtful read per week, free.

Recommended next step

If your bloodwork suggests insulin resistance

Insulin resistance and rising HbA1c respond best to lifestyle + sometimes a metabolic support stack. We've reviewed citrus polyphenol formulations (the active class behind hesperidin/naringin metabolism research) — CitrusBurn is the formulation we recommend if your HbA1c is climbing and you want a supportive intervention while you make the lifestyle changes that actually move the number. Affiliate disclosed — see our disclosure.

Sources and citations: Diabetes Care 2010, 33 Suppl 1:S62-S69 (HbA1c thresholds); JAMA 2019, 321(10):961-963 (ApoB vs LDL-C); American Thyroid Association 2014 clinical guidelines (TSH ranges); Endocrine Reviews 2019, 40(4):1109-1151 (vitamin D and aging); Blood 2017, 130(15):1731-1733 (RDW as mortality predictor); ACOG Practice Bulletin 141, 2014 (perimenopausal hormone assessment). All references are open-access or available via library proxies; the Sunday letter is reader-funded and free of any laboratory or supplement-brand sponsorship.

Related reading

HRT after the 2024 reanalyses→ Read this letter Magnesium for sleep at 50→ Read this letter The cortisol-belly research→ Read this letter

The Sunday letter

Free. Research-led. One thoughtful letter a week on the decade media gets wrong.

After Forty Feel is independent editorial. Reader-funded. Some links in our writing are affiliate links — when they are, we disclose. No supplement brand sponsorships, ever. This letter is informational and not a substitute for medical advice from a clinician who knows you.